Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hormoz Ayromlou

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
Pharmacological Reports : PR|October 20, 2018
Nanocurcumin is a potential novel therapy for multiple sclerosis by influencing inflammatory mediatorsSanam Dolati, Majid Ahmadi, Leili Aghebti-Maleki, et al.
International Immunopharmacology|June 1, 2018
Changes in Th17 cells function after nanocurcumin use to treat multiple sclerosisSanam Dolati, Majid Ahmadi, Reza Rikhtegar, et al.
Cytokine|May 1, 2024
Epstein-Barr virus-encoded BART9 and BART15 miRNAs are elevated in exosomes of cerebrospinal fluid from relapsing-remitting multiple sclerosis patientsMina Mohammadinasr, Soheila Montazersaheb, Vahid Hosseini, et al.
Journal of Neuroendocrinology|June 15, 2023
Insulin resistance is associated with cognitive dysfunction in multiple sclerosis patients: A cross-sectional studyHormoz Ayromlou, Samaneh Hosseini, Mohammad Khalili, et al.
The Malaysian Journal of Medical Sciences : MJMS|September 18, 2013
Electrodiagnostic evaluation of peripheral nervous system changes in patients with multiple sclerosisHormoz Ayromlou, Hadi Mohammad-Khanli, Mohammad Yazdchi-Marandi, et al.
Biomarker Research|June 25, 2016
The effect of n-3 polyunsaturated fatty acids on incidence and severity of oxaliplatin induced peripheral neuropathy: a randomized controlled trialAli Esfahani, Mohammad Hossein Somi, Hormoz Ayromlou, et al.
Journal of Neuroimmunology|March 22, 2020
miR-504 expression level is increased in multiple sclerosis patients responder to interferon-betaMahsa Tahmasebivand, Seyyed Reza Mousavi, Mehdi Khorrami, et al.
Journal of Research in Medical Sciences : the Official Journal of Isfahan University of Medical Sciences|January 27, 2012
Genetic association of TNF-α-308 G/A and -863 C/A polymorphisms with late onset Alzheimer's disease in Azeri Turk population of IranSeiied Moitaba Mohaddes Ardebili, Tarlan Yeghaneh, Jalal Gharesouran, et al.
Galen Medical Journal|September 1, 2021
Antidepressant Effects of a Persian Medicine Remedy on Multiple Sclerosis Patients: A Double-Blinded Randomized Clinical TrialMaryam Adalat, Mohammad Khalili, Hormoz Ayromlou, et al.
ISRN Neurology|August 14, 2012
Diagnostic value of ultrasonography and magnetic resonance imaging in ulnar neuropathy at the elbowHormoz Ayromlou, Mohammad K Tarzamni, Mohammad Hossein Daghighi, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Pharmacological Reports : PR|October 20, 2018
Nanocurcumin is a potential novel therapy for multiple sclerosis by influencing inflammatory mediatorsSanam Dolati, Majid Ahmadi, Leili Aghebti-Maleki, et al.
International Immunopharmacology|June 1, 2018
Changes in Th17 cells function after nanocurcumin use to treat multiple sclerosisSanam Dolati, Majid Ahmadi, Reza Rikhtegar, et al.
Cytokine|May 1, 2024
Epstein-Barr virus-encoded BART9 and BART15 miRNAs are elevated in exosomes of cerebrospinal fluid from relapsing-remitting multiple sclerosis patientsMina Mohammadinasr, Soheila Montazersaheb, Vahid Hosseini, et al.
Journal of Neuroendocrinology|June 15, 2023
Insulin resistance is associated with cognitive dysfunction in multiple sclerosis patients: A cross-sectional studyHormoz Ayromlou, Samaneh Hosseini, Mohammad Khalili, et al.
The Malaysian Journal of Medical Sciences : MJMS|September 18, 2013
Electrodiagnostic evaluation of peripheral nervous system changes in patients with multiple sclerosisHormoz Ayromlou, Hadi Mohammad-Khanli, Mohammad Yazdchi-Marandi, et al.
Biomarker Research|June 25, 2016
The effect of n-3 polyunsaturated fatty acids on incidence and severity of oxaliplatin induced peripheral neuropathy: a randomized controlled trialAli Esfahani, Mohammad Hossein Somi, Hormoz Ayromlou, et al.
Journal of Neuroimmunology|March 22, 2020
miR-504 expression level is increased in multiple sclerosis patients responder to interferon-betaMahsa Tahmasebivand, Seyyed Reza Mousavi, Mehdi Khorrami, et al.
Journal of Research in Medical Sciences : the Official Journal of Isfahan University of Medical Sciences|January 27, 2012
Genetic association of TNF-α-308 G/A and -863 C/A polymorphisms with late onset Alzheimer's disease in Azeri Turk population of IranSeiied Moitaba Mohaddes Ardebili, Tarlan Yeghaneh, Jalal Gharesouran, et al.
Galen Medical Journal|September 1, 2021
Antidepressant Effects of a Persian Medicine Remedy on Multiple Sclerosis Patients: A Double-Blinded Randomized Clinical TrialMaryam Adalat, Mohammad Khalili, Hormoz Ayromlou, et al.
ISRN Neurology|August 14, 2012
Diagnostic value of ultrasonography and magnetic resonance imaging in ulnar neuropathy at the elbowHormoz Ayromlou, Mohammad K Tarzamni, Mohammad Hossein Daghighi, et al.
Pageof 4